<DOC>
	<DOCNO>NCT02065349</DOCNO>
	<brief_summary>The purpose study ass painkilling efficacy ASP8477 relative mock ( placebo ) patient diagnose painful diabetic peripheral neuropathy postherpetic neuralgia determine change average daily pain intensity patient initially respond favorably treatment ASP8477 .</brief_summary>
	<brief_title>A Study Into Pain Relief Given ASP8477 Peripheral Neuropathic Pain ( Either Post-herpetic Neuralgia Painful Diabetic Peripheral Neuropathy ) Its Safety</brief_title>
	<detailed_description>The study consist Screening Period , Single-Blind Treatment Period , Double-Blind Randomized Withdrawal Period Follow-up Period .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>PDPN subject must : Established diagnosis diabetes ( type I II ) painful diabetic peripheral neuropathy glycosylated hemoglobin ( HbA1c ) ≤ 11 % Screening . Stable glycemic control ( HbA1c ≤ 11 % ) achieve drug regimen least 3 month prior Screening . At least 1year history DPN pain . Diabetic distal symmetrical polyneuropathy symptom ( include pain ) stable least last 3 month prior Screening base PI judgment subjectreported medical history . PHN subject must pain present ≥ 6 month heal herpes zoster rash . Subject significant pain etiology PDPN PHN , clearly non differentiate pain , plantar fasciitis , heel spur , tibial neuropathy , Morton 's neuroma , bunion , metatarsalgia , arthritis foot , ischemic pain , neurological disorder unrelated diabetic neuropathy , skin condition area neuropathy could alter sensation , malignancy , current orthostatic hypotension , hypo hypertension , syncope clinically significant ECG , clinical intolerance Nonsteroidal antiinflammatory drug ( NSAIDs ) ASP8477 , depression , psychosis psychiatric neurological illness , BMI 35 , renal impairment failure , alcohol ( ETOH ) drug abuse , GI complaint . Previous investigational therapy within 28 day 5 half life</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>peripheral neuropathy</keyword>
	<keyword>PDPN</keyword>
	<keyword>PHN</keyword>
	<keyword>pain</keyword>
</DOC>